A multicenter prospective cohort study performed at 6 major teaching hospitals in Southern Norway to study patient reported outcomes, lung function and pulmonary CT in patients at 3 and 12 months after hospitalization for coronavirus disease 2019 (COVID-19).
This cohort study aim to describe the Natural course of COVID-19 disease in an consecutive
and unselected cohort of Norwegians that have been hospitalized.
In addition to the primary and secondary outcomes related to PROMS, lung function and
pulmonary CT, the study also have several substudies: Cardiology: The study includes
echocardiography, 24-h electrocardiography and cardiopulmonary exercise test.
ENT: The study includes CT of head sinuses and patient-reported sleep disturbances and nose
symptoms in a subgroup of patients.
Laboratory: Analyses of common markers of inflammation and cardiac biomarkers.
Other: No interventions
No interventions
Inclusion Criteria:
- Discharged before June 1 2020 after hospitalization at participating hospital for
COVID-19
Exclusion Criteria:
- Age < 18 years
- Dementia
- Living outside hospital catchment area
- Participation in WHO COVID-19 clinical trial
Dept Pulmonary Medicine
Lørenskog, Viken, Norway
Gunnar Einvik, PhD, Principal Investigator
University Hospital, Akershus